Investigation of Therapeutic Drugs Targeting Eps8 for Colorectal Cancer Treatment
碩士 === 國立成功大學 === 藥理學研究所 === 103 === Colorectal cancer is the third most common cancer in the world. It has been reported that Eps8, epidermal growth factor receptor pathway substrate 8, is expressed at elevated levels in colon cancer and high levels of Eps8 results in poor prognosis of cancer patie...
Main Authors: | CremildaLai, 賴啟楹 |
---|---|
Other Authors: | Tzeng-Horng Leu |
Format: | Others |
Language: | en_US |
Published: |
2015
|
Online Access: | http://ndltd.ncl.edu.tw/handle/31300061197120178665 |
Similar Items
-
Reduced Eps8 expression by sodium butyrate treatment in colorectal cancer cells
by: Hsiu-Shan Yu, et al.
Published: (2002) -
Reduced Eps8 expression by sodium butyrate treatment in colorectal cancer cells
by: Hsiu-Shan Yu, et al.
Published: (2002) -
Participation of Eps8 in COX-2-mediated colorectal cancer formation
by: Meng-Shan Tsai, et al.
Published: (2006) -
EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
by: Mousumi Majumder, et al.
Published: (2018-03-01) -
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
by: Srinivas Patnaik, et al.
Published: (2019-06-01)